WAM
CBMG

Wolverine Asset Management’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Wolverine Asset Management’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,787
Closed -$602K – 2508
2020
Q4 		$602K Buy
32,787
+2,976
+10% +$54.2K ﹤0.01% 789
2020
Q3 		$546K Buy
+29,811
New +$501K ﹤0.01% 714

Wolverine Asset Management's CBMG Position: Q1 2021 in Review

Wolverine Asset Management sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 32,787 shares — an estimated $602K sold.

Wolverine Asset Management first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $602K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Wolverine Asset Management reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Wolverine Asset Management sold 32,787 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $602K.
  • Wolverine Asset Management first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
  • Wolverine Asset Management's Cellular Biomedicine Group, Inc. position peaked at $602K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Wolverine Asset Management's 13F filing for Q1 2021, filed 13 May 2021.